Infectious Disease & Immunology

Advancing HIV Clinical Research

HIV continues to impact millions worldwide, creating an ongoing need for innovative therapies, prevention strategies, and long-term care solutions. CenExel partners with sponsors to accelerate HIV clinical trials through experienced investigators, diverse patient populations, and high-quality research execution across all phases of development.

Studies Conducted
0 +
Trial Participants
0 +
Active Sites
0 +
Overview

Leading HIV Clinical Research Excellence

CenExel provides specialized expertise in HIV clinical research, supporting sponsors with scientific leadership, operational excellence, and patient-focused trial management. Our experienced teams help accelerate enrollment, improve retention, and deliver reliable data from early-phase studies through post-marketing trials.

Diverse Patient Recruitment

We engage broad and representative patient populations to support inclusive and effective HIV clinical trials.

Accelerated Trial Execution

Our experienced site network helps sponsors improve timelines and streamline study operations.
Conditions Covered

HIV & Infectious Diseases We Research

Our HIV research programs support a wide range of infectious disease studies, prevention therapies, and treatment advancements.

  • HIV-1 Infection
  • HIV Prevention (PrEP)
  • Antiretroviral Therapy (ART)
  • HIV Treatment Resistance
  • Viral Suppression Studies
  • Long-Acting Injectable Therapies
  • HIV & Aging Research
  • HIV-Associated Neurological Disorders
Our Approach

Why Sponsors Choose CenExel for HIV Research

CenExel combines scientific expertise, diverse recruitment strategies, and operational excellence to help sponsors successfully execute HIV clinical trials.

01

Diverse Enrollment

Our site network supports broad patient recruitment to ensure inclusive representation across HIV studies.

02

Long-Term Retention

We implement patient-centered engagement strategies that improve retention and study continuity.

03

Experienced Investigators

Our infectious disease specialists bring extensive experience in HIV therapies and prevention research.

04

Faster Study Activation

CenExel accelerates study startup timelines through centralized operations and efficient site coordination.

Phase Coverage

Supported HIV Trial Phases

CenExel supports Phase I through Phase IV HIV clinical trials, including prevention, treatment optimization, vaccine development, and long-term outcomes research.

Active across all phases
  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Our teams support first-in-human studies, long-acting therapy trials, vaccine programs, and post-marketing observational studies with a focus on patient safety and data quality.

HIV Task Force

CenExel supports a broad range of HIV and infectious disease clinical trials, including prevention therapies, treatment optimization, long-acting injectables, and immune-response research across diverse patient populations.

Active Sites

18 Sites

CenExel Phoenix
CenExel Anaheim
CenExel Atlanta
CenExel Marlton
CenExel Gaithersburg

Our Blog